COX-2 inhibitors: a potential target for drug therapy in the management of colorectal cancer (original) (raw)

COX-2 inhibition as a tool to treat and prevent colorectal cancer

Critical Reviews in Oncology/Hematology, 2004

A Review: Role of Cyclooxygenase- 2 Inhibitors in Treatment of Colorectal Cancer

Journal of Current Pharma Research

Association between COX-2 expression and effectiveness of COX-2 inhibitors in a phase II trial in patients with metastatic colorectal adenocarcinoma

Lance Heilbrun

Anticancer research, 2012

View PDFchevron_right

Role of cyclooxygenase-2 inhibitors in the survival outcome of colorectal cancer patients: A population-based cohort study

Kun-Pin Hsieh

The Kaohsiung Journal of Medical Sciences, 2017

View PDFchevron_right

The Relationship of Cyclooxygenase -2 (COX-2) Expression with Clinical Presentation, Staging, and Degree of Differentiation in Colorectal Cancer

Julianus A B O Y A M A N Uwuratuw

International Journal of Sciences: Basic and Applied Research, 2017

View PDFchevron_right

Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells

JEANELLE MARTINEZ

Carcinogenesis, 2003

View PDFchevron_right

The relationship between cyclooxygenase-2 expression and colorectal cancer

Ronan Conroy M Conroy, Diarmuid O'Donoghue

JAMA: The Journal of …, 1999

View PDFchevron_right

Clinicopathologic significance of cyclooxygenase-2 overexpression in colorectal adenocarcinoma

Si-Hyong Jang

Basic and Applied Pathology, 2010

View PDFchevron_right

Elder DJE, Halton DE, Hague A, Paraskeva CInduction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin Cancer Res 3: 1679-1683

Angela Hague

Clinical Cancer Research

View PDFchevron_right

Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression

Angela Hague

Clinical cancer research : an official journal of the American Association for Cancer Research, 1997

View PDFchevron_right

Cyclooxygenase-2 Expression: A Significant Prognostic Indicator for Patients With Colorectal Cancer

Labile Soumaoro

Clinical Cancer Research, 2004

View PDFchevron_right

Expression of Cyclooxygenase-2 (COX-2) in Colorectal Adenocarcinoma: an Immunohistochemical and Histopathological Study

Fahad Hussain

Asian Pacific Journal of Cancer Prevention, 2014

View PDFchevron_right

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2

Susan Kirkland

Journal of Clinical Investigation, 1997

View PDFchevron_right

Cyclooxygenase-2 and Gastrointestinal Cancer

Jason Mann

The Cancer Journal, 2004

View PDFchevron_right

Differential expression of cyclooxygenase 2 in human colorectal cancer

Angela Ianaro

Gut, 1999

View PDFchevron_right

Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522

Eiji Sunami

British journal of cancer, 1999

View PDFchevron_right

Over-Expression of Cyclooxygenase-2 in Colorectal Cancer Patients

Ram Rattan, Vijayta Chadha

Asian Pacific Journal of Cancer Prevention

View PDFchevron_right

Role of cyclooxygenase-2 in the angiogenesis of colorectal cancer

Alexander Seifalian

International Journal of Colorectal Disease, 2004

View PDFchevron_right

Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer

Eiji Sunami

British journal of cancer, 2000

View PDFchevron_right

High cyclooxygenase-2 expression is associated with advanced stages in colorectal cancer

Seppo Pyrhönen

Anticancer research, 2013

View PDFchevron_right

Combined activity of COX-1 and COX-2 is increased in non-neoplastic colonic mucosa from colorectal neoplasia patients

Thorbjørn Jensen

BMC gastroenterology, 2018

View PDFchevron_right

Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma

Eman Emam, Jaudah Al-maghrabi, Abdulrahman Sibiany

World Journal of Gastroenterology, 2012

View PDFchevron_right

Cyclooxygenase-2 Expression in Right- and Left-Sided Colon Cancer: A Rationale For Optimization of Cyclooxygenase-2 Inhibitor Therapy

Domenico Coppola

Clinical Colorectal Cancer, 2004

View PDFchevron_right

Protective Effects of Long-Term Usage of Cyclo-Oxygenase-2 Inhibitors on Colorectal Cancer in Genetically Predisposed Individuals and Their Overall Effect on Prognosis: A Systematic Review

basim Ameen

Cureus

View PDFchevron_right

International Journal of Research in Pharmacy and Chemistry Role of CYCLOOXYGENASE-2 in Cancer

Chetan Rajendra Sonawane

View PDFchevron_right

Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer

Abderrahmane Kadi

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2006

View PDFchevron_right

Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer

Masaichi Ohira

International Journal of Cancer, 2002

View PDFchevron_right

Cancer Prevention: A New Era beyond Cyclooxygenase-2

Khosrow Kashfi

Journal of Pharmacology and Experimental Therapeutics, 2005

View PDFchevron_right

Regression of hepatocellular carcinoma due to cyclooxygenase (COX)-2 inhibitor

Kazufumi Dohmen

The American journal of gastroenterology, 2006

View PDFchevron_right

The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence

Elham Rahme

Gastroenterology, 2003

View PDFchevron_right

Cox-2 is needed but not sufficient for apoptosis induced by Cox-2 selective inhibitors in colon cancer cells

Petr Protiva

Apoptosis, 2000

View PDFchevron_right

Cyclooxygenase-2 inhibition in colon experimental carcinogenesis

Jose Noguera

Revista Española de Enfermedades Digestivas, 2005

View PDFchevron_right

Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force

Alexander Tsertsvadze

Annals of Internal Medicine, 2007

View PDFchevron_right

Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition

Reiner Jänicke

Oncogene, 2003

View PDFchevron_right

COX-2 inhibitors: a potential target for drug therapy in the management of colorectal cancer (original) (raw)

Related papers